Sonorant

WIPO WIPO 2019

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark Sonorant was filed as Word mark on 04/03/2019 at the World Intellectual Property Organization.

Trademark Details Last update: February 22, 2022

Trademark form Word mark
File reference 1482014
Countries Australia bx Switzerland China em United Kingdom Israel Japan South Korea Mexico Norway New Zealand Russia Singapore Thailand Turkey
Base trademark IE No. 2019/00583, March 23, 2019
Application date April 3, 2019
Expiration date April 3, 2029

Trademark owner

College Business & Technology Park,
Cruiserath Road,
IE

Trademark representatives

195 Arlington Heights Road, Suite 125 US

goods and services

05 Pharmaceutical preparations; pharmaceutical preparations for the treatment of neurological diseases and disorders, nephrotic diseases, endocrine disorders, rheumatic disorders, collagen diseases, dermatologic diseases and disorders, allergic states, ophthalmic diseases, respiratory diseases, hematologic disorders, neoplastic diseases, edematous state, gastrointestinal diseases, hepatic diseases and disorders, biliary diseases and disorders, renal disorders, cardiovascular and lipid-related diseases and disorders, inflammatory and autoimmune diseases and disorders; intravenous analgesics and antipyretics; medical gases for inhalation; bioengineered tissues for surgical implantation
10 Medical devices; medical apparatus; medical apparatus and instruments for use in connection with the administration of gases to patients for medical and therapeutic purposes and accessories and parts thereof, namely, medical and therapeutic gas delivery systems comprised primarily of gas cylinders, valves, regulators, flow meters, delivery hoses and apparatus and instruments for setting, measuring and regulating the mixture of medical and therapeutic gases delivered to patients; therapeutic medical device and accessories and parts thereof for extracting blood from the body, separating blood, treating it extracorporally, and returning it to the body used for extracorporeal photopheresis, extracorporeal photo immune therapy, extracorporeal photo chemotherapy, and cellular therapies; devices incorporating prefilled syringe containing injectable pharmaceuticals for manual injection
40 Custom manufacturing services for pharmaceuticals and active pharmaceutical ingredients
41 Training, service and educational support in the fields of pharmaceuticals and medical devices
42 Scientific research services for medical purposes

Trademark history

Date Document number Area Entry
February 8, 2022 2022/8 Gaz CH RAW: Rule 18ter(2)(ii) GP following a provisional refusal
June 17, 2021 2021/25 Gaz JP RAW: Rule 18ter(2)(ii) GP following a provisional refusal
June 2, 2021 2021/22 Gaz MX Rejection
March 26, 2021 2021/14 Gaz TH Rejection
December 23, 2020 2020/52 Gaz TR Rejection
December 10, 2020 2020/50 Gaz JP Rejection
November 3, 2020 2020/47 Gaz IL RAW: Rule 18ter(2)(ii) GP following a provisional refusal
October 21, 2020 2020/43 Gaz KR Rejection
October 15, 2020 2020/42 Gaz BX Rejection
September 10, 2020 2020/37 Gaz NO Rejection
July 29, 2020 2020/33 Gaz CH Rejection
July 15, 2020 2020/34 Gaz SG RAW: Rule 18ter(2)(ii) GP following a provisional refusal
April 22, 2020 2020/17 Gaz AU Rejection
March 19, 2020 2020/13 Gaz RU Rejection
March 18, 2020 2020/13 Gaz IL Rejection
March 11, 2020 2020/11 Gaz NZ Rejection
January 21, 2020 2020/4 Gaz CN Rejection
January 15, 2020 2020/3 Gaz GB Rejection
January 14, 2020 2020/3 Gaz EM Rejection
December 14, 2019 2019/51 Gaz SG Rejection
September 10, 2019 2019/41 Gaz Correction
April 3, 2019 2019/30 Gaz IE Registration

ID: 141482014